Kelley Dealhoy – Biography
Last update: April 3, 2026Executive profile
Kelley was World Wide Head Business Development & Licensing Cardiovascular, Renal & Metabolism and Vice President of Business Development and Licensing Pharma at Novartis US, and Vice President, Business Development and Licensing at Ripple Therapeutics. Kelley Dealhoy joined ONO Pharmaceutical in 2022.
Kelley Dealhoy is currentlySenior Vice President and Chief Business Officer at Deciphera Pharmaceuticals - View - Deciphera Pharmaceuticals org chart
Create your alert
to follow the career of Kelley Dealhoy.
Education
In 1993, Kelley Dealhoy completed a Bachelor of Science in Biochemistry at Queen's University.
They have also studied at Queen's University :
Find more alumni from Queen's University
More about Kelley Dealhoy
Selected links
Do you need to know more about Kelley Dealhoy? More results.
Participate
Social media
- Kelley Dealhoy on Google News, X (Twitter), LinkedIn, YouTube
- View the pictures of Kelley Dealhoy
The colleagues of Kelley Dealhoy
Company Colleagues
- At Deciphera Pharmaceuticals, Kelley Dealhoy has 26 colleagues including Ryota Udagawa (CEO & President), Toichi Takino (Director)…
Industry Colleagues
- In the Pharmaceuticals industry, Kelley Dealhoy has 22,991 colleagues in 1,914 companies located in 68 countries. 10,821 executive movements have been recorded in the last 12 months. Learn more about Pharmaceuticals.
Report an error
Update the org chart details of Kelley Dealhoy.
Get in Touch
Here are a few tips for establishing great contacts.
